On the other hand, in patients suffering from melanoma (a type of skin cancer) treated with PD0325901, the loss of PTEN was associated with a poor response of melanoma cells treated with the GSI RO4929097 (a gamma-secretase inhibitor). Here, PTEN is linked to melanoma.